Competitor Analysis: Cardiovascular Peptides

Publisher: La Merie Publishing
Pages: 59
Format: PDF and Online
Product Line:
Competitor Analysis
Product Code: LMCA0106
Release Date: October of 2014

300.00 €
Free of 21 % VAT (except in Spain and also in the European Union without valid intl. VAT no),
Delivery costs do not apply or are included.
You can also order this product via email or fax , please download the Order Form
Need more information?
Ask a question about this product

Competitor Analysis: Cardiovascular Peptides

The present Competitive Intelligence Report about Cardiovascular Peptides used to treat or prevcent heart failure, myocardial infarction, thrombosis, hypertension, peripheral vascular diseases, hemostasis and wound sealing provides a competitor evaluation in the field of R&D projects with cardiovascular peptides as of October 2014. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report includes a compilation of current active projects in research and development of cardiovasuclar peptides. In addition, the report lists company-specific R&D pipelines of cardiovascular peptides. Competitor projects are listed in a tabular format providing information on:

  • Drug Codes,
  • Target / Mechanism of Action,
  • Class of Compound,
  • Company,
  • Product category,
  • Indication,
  • R&D Stage and
  • additional comments with a hyperlink leading to the source of information.

About Competitor Analysis Series
The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.


Competitor Analysis: Cardiovascular Peptides

Table of Contents

  • 2013 Sales of Major Cardiovascular Peptides
  • Acute Care & Reperfusion Injuries
  • Heart Failure
  • Coronary Ischemia & Myocardial Infarction
  • Cardiometabolic Disease & Atherosclerosis
  • Peripheral Vascular Disease
  • Hypertension
  • Pulmonary Artery Hypertension
  • Hemostasis, Wound Sealing & Prevention of Thrombosis
  • Hematologic Diseases
  • Corporate Cardiovascular Peptide R&D Pipelines

The above shown price refers to a Single User License. Please contact us for prices of departmental, site or global product licenses.

This Report is NOT a downloadable item but will be delivered via email within 24 h (working days only).

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up